Switzerland - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA)
Since 2014, Switzerland Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA) grew 5.4% year on year. In 2019, the country was ranked number 1 comparing other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA) with €665.57 Per Capita. Germany, Liechtenstein and Belgium respectively ranked number 2, 3 and 4 in this ranking. Switzerland witnessed the best average annual growth at +5.4% per year, while Portugal was the worst growing country at -12.9% per year.
| Date | Euros Per Capita |
|---|---|
| 2019 | 665.57 |
| 2018 | 645.22 |
| 2017 | 651.57 |
| 2016 | 634.72 |
| 2015 | 615.16 |
Download all data from 2010 to 2019
How does Switzerland rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Compulsory Contributory Health Insurance Schemes and Compulsory Medical Saving Accounts (CMSA)?
| # | 23 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
Switzerland
|
665.57 | 2019 | +3.1 % | +5.3 % | View data |
| 2 |
#2
Germany
|
524.79 | 2019 | +2.3 % | +3.0 % | View data |
| 3 |
#3
Liechtenstein
|
522.20 | 2019 | +3.4 % | +0.9 % | View data |
| 4 |
#4
Belgium
|
420.62 | 2019 | +0.4 % | +3.9 % | View data |
| 5 |
#5
France
|
412.39 | 2019 | +0.6 % | +1.9 % | View data |